This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovations of Daniel F J Vernier
Introduction
Daniel F J Vernier is a notable inventor based in Val de Reuil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target mycobacterial diseases. His work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
Daniel F J Vernier holds a patent for "Mycobacterial inhibitors." This invention relates to novel substituted quinoline derivatives, which are useful for treating mycobacterial diseases. The patent details compounds that include various stereochemical and tautomeric forms, as well as their N-oxide forms. The claimed compounds are particularly effective against pathogenic mycobacteria, providing a promising avenue for therapeutic development.
Career Highlights
Vernier is associated with Janssen Pharmaceutica NV, a company known for its focus on innovative pharmaceutical solutions. His work at Janssen has allowed him to contribute to significant advancements in the treatment of infectious diseases. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, Daniel F J Vernier has collaborated with esteemed colleagues, including Jozef Frans Elisabetha Van Gestel and Jérôme Emile Georges Guillemont. These collaborations have fostered a productive environment for innovation and have led to the successful development of new therapeutic agents.
Conclusion
Daniel F J Vernier's contributions to the field of pharmaceuticals, particularly through his patent on mycobacterial inhibitors, highlight his role as an influential inventor. His work continues to impact the treatment of mycobacterial diseases, showcasing the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
